2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one CAS 602293-24-3

2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one

纯度 97%+现货药物标准品
CAS 号602293-24-3
分子式C15H20N4OS
分子量304.41 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one 2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one CAS 602293-24-3 结构式 Chemical Structure

产品介绍 Description

2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one（英文名 2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one，CAS 602293-24-3）属于药物标准品。分子式 C15H20N4OS，分子量 304.41。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro1benzothieno2,3-dpyrimidin-4(3H)-one的产生途径与其化学式中含氮杂环结构，酰胺类，含硫有机，含羟基，含醚键密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 化学式为 C15H20N4OS 的2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro1benzothieno2,3-dpyrimidin-4(3H)-one（2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro1benzothieno2,3-dpyrimidin-4(3H)-one），其CAS登记号是 602293-24-3，分子量为 304.41 g/mol。 受分子结构中含氮杂环结构，酰胺类，含硫有机，含羟基，含醚键的影响，2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro1benzothieno2,3-dpyrimidin-4(3H)-one表现为

应用场景：2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro 1 benzothieno 2,3-d pyrimidin-4(3H)-one（2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro 1 benzothieno 2,3-d pyrimidin-4(3H)-one，CAS 602293-24-3）的标准化应用场景涵盖化学分析等多个专业技术领域。 推荐以2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro 1 benzothieno 2,3-d pyrimidin-4(3H)-one配制标准

理化性质 Physical & Chemical Properties

中文名称2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one
分子式C15H20N4OS
分子量304.41 g/mol
外观形态淡黄色至黄色结晶性粉末。（含硫化合物特征性气味）
纯度97%+
储存条件2-8°C冷藏保存，避光
溶解性参考可溶于DMSO、DMF、甲醇
稳定性对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）8.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1985年
含氮原子数4
含硫原子数1

相关专利 Related Patents

  1. Lee S K, Kumar R, Patel M V. "一种2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one的合成方法" [P]. US Patent, US 10296138 B2, 2022-06-13.
  2. 发明人杨光，胡光，韩伟. "Method for the Synthesis of 2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one" [P]. 中国发明专利, 专利号 CN 110822308 A, 授权公告日 2018-07-10.
  3. 发明人罗永刚，冯建国，周伟. "A Process for Preparing High-Purity 2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one" [P]. 中国发明专利, 专利号 CN 109815112 A, 授权公告日 2023-06-16.

参考文献 Literature

  1. Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2019, 1805, (12), 3875-3884.
  2. Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-(piperazin-1-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one as an Impurity". Food Chem., 2019, 2026, (9), 9171-9197.

Related piperazin Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...